Credit Suisse Maintains Outperform on Nasdaq, Lowers Price Target to $189
Credit Suisse analyst Gautam Sawant maintains Nasdaq (NASDAQ:NDAQ) with a Outperform and lowers the price target from $221 to $189.
Truist Securities Maintains Buy on Centene, Raises Price Target to $102
Truist Securities analyst David Macdonald maintains Centene (NYSE:CNC) with a Buy and raises the price target from $100 to $102.
Truist Securities Maintains Buy on Amedisys, Lowers Price Target to $150
Truist Securities analyst David Macdonald maintains Amedisys (NASDAQ:AMED) with a Buy and lowers the price target from $175 to $150.
Truist Securities Maintains Buy on AdaptHealth, Raises Price Target to $24
Truist Securities analyst David Macdonald maintains AdaptHealth (NASDAQ:AHCO) with a Buy and raises the price target from $20 to $24.
Truist Securities Maintains Buy on Agilon Health, Raises Price Target to $33
Truist Securities analyst David Macdonald maintains Agilon Health (NYSE:AGL) with a Buy and raises the price target from $30 to $33.
Truist Securities Maintains Hold on trivago, Lowers Price Target to $2.3
Truist Securities analyst Naved Khan maintains trivago (NASDAQ:TRVG) with a Hold and lowers the price target from $3 to $2.3.
Truist Securities Maintains Hold on Airbnb, Lowers Price Target to $120
Truist Securities analyst Naved Khan maintains Airbnb (NASDAQ:ABNB) with a Hold and lowers the price target from $160 to $120.
Stifel Maintains Buy on Align Tech, Lowers Price Target to $375
Stifel analyst Jonathan Block maintains Align Tech (NASDAQ:ALGN) with a Buy and lowers the price target from $425 to $375.
Truist Securities Maintains Buy on Booking Holdings, Lowers Price Target to $2600
Truist Securities analyst Naved Khan maintains Booking Holdings (NASDAQ:BKNG) with a Buy and lowers the price target from $3000 to $2600.
Credit Suisse Downgrades Himax Technologies to Neutral, Announces $7 Price Target
Credit Suisse analyst Jerry Su downgrades Himax Technologies (NASDAQ:HIMX) from Outperform to Neutral and announces $7 price target.